An estimated 1 in 8 women live with polycystic ovarian syndrome, commonly referred to as PCOS. However, the name is a bit of a misnomer; it suggests that the condition affects only the ovaries. In actuality, the condition is a broader metabolic and hormonal disorder. After years of research and patient advocacy, a recent report in The Lancet announced a new designation to reflect the condition’s whole-body impact: polyendocrine metabolic ovarian syndrome (PMOS).
Continue Reading this article here
